Octave Bioscience
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1440 Obrien Dr Ste B, Menlo Park, Califo...Phone Number
(650) 233-2750Website
www.octavebio.comRevenue
$22.8 MillionIndustry
About Octave Bioscience
Octave Bioscience, Inc specializes in the development of innovative diagnostic tests, particularly the MSDA Test, which is the first multi-analyte blood test designed to monitor multiple sclerosis (MS) disease activity. This test provides detailed, personalized reporting that empowers both patients and healthcare providers to make informed care decisions. The company aims to enhance clinical insights for neurodegenerative diseases, thereby transforming patient care. Their services are available nationwide through Quest Diagnostics, targeting both healthcare providers and patients affected by MS.Explore more
Octave Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Octave Bioscience
Compare insights from companies similar to Octave Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Octave Bioscience Tech Stack
A closer look at the technologies used by Octave Bioscience
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Octave Bioscience
Sign Up For FreeTo access detailed company insights
Octave Bioscience, Inc specializes in the development of innovative diagnostic tests, particularly the MSDA Test, which is the first multi-analyte blood test designed to monitor multiple sclerosis (MS) disease activity. This test provides detailed, personalized reporting that empowers both patients and healthcare providers to make informed care dec... Read More
